← Back to Search

SMS Text Messaging for Type 2 Diabetes

N/A
Waitlist Available
Led By Michael Wolf, PhD MPH
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after baseline
Awards & highlights

Study Summary

This trial will test whether a Universal Medication Schedule (UMS) can help patients with diabetes safely use and adhere to their complex drug regimens. The UMS standardizes the prescribing and dispensing of medicine by using health literacy principles and more explicit times to describe when to take medicine (morning, noon, evening, bedtime). The proposed intervention will standardize prescribing within an electronic health record (EHR) so all medication orders include UMS prescription instructions ('sigs') and patients receive a medication information sheet with their after-visit summaries. Additionally, to help patients remember when to take prescribed medicines, the trial will link unid

Eligible Conditions
  • Type 2 Diabetes
  • Medication Adherence

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication Adherence: Pill Count
Secondary outcome measures
Medication Adherence: 24-hour Recall
Medication Adherence: ASK-12
Treatment Knowledge

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: UMS Strategy + SMS Text MessagingExperimental Treatment2 Interventions
In addition to the components from the UMS strategy arm, patients will receive daily text message reminders for 6 months.
Group II: UMS StrategyExperimental Treatment1 Intervention
Patients of providers randomized to the UMS arm will receive study-related educational tools at their primary care visit to support the understanding, regimen consolidation, and use of prescriptions. These materials will be generated within the electronic health record. Prescription instructions will be adapted to the UMS format to establish four standard time intervals (morning, noon, evening, bedtime) for prescribing and dispensing of medicine. UMS instructions also use simplified text and numeric characters instead of words to detail dose. Single-page, plain language medication information sheets with important medication-related information following health literacy best practices.
Group III: Usual CareActive Control1 Intervention
Patients of providers randomized to the usual care arm will receive their standard care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UMS Strategy
2018
N/A
~1220
SMS Text Messaging
2018
N/A
~770

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER
1,636 Previous Clinical Trials
2,559,806 Total Patients Enrolled
Northwestern Memorial HospitalOTHER
40 Previous Clinical Trials
15,949 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
916,464 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Regimen Education and Messaging in Diabetes (REMinD)
Michael S. Wolf 2018. "Regimen Education and Messaging in Diabetes (REMinD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03185741.
~106 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top